Scientific Glossary

Organ-on-Chip Systems→ Organoids Complete Guide→ Microphysiological Systems (MPS)→ Digital Twins in Healthcare→ iPSC Technology→ New Approach Methodologies (NAMs)→ Liver Models→ Kidney Models→ Heart Models→ Quantum Drug Discovery→

Brain Organoids Research→ Liver Toxicity Testing→ Lung Organoids→ Kidney Nephrotoxicity→ Cardiac Safety Testing→ Gut Microbiome Models→ Blood-Brain Barrier→ Skin-on-Chip→ Tumor Organoids & Cancer→ Retinal Organoids→ Pancreatic Organoids→ Colon Organoids→ Prostate Organoids→ Ovarian Organoids→ Thyroid Organoids→ Bladder Organoids→ Bone Marrow Organoids→ Placenta-on-Chip→ Assembloids→ Multi-Organ Systems→ Vascularization Advances→ Biosensors Integration→ CRISPR & Organoids→ iPSC Disease Modeling→ Single-Cell Analysis→ High-Throughput Screening→ Clinical Trials in a Dish→ Organoid Biobanking→ Organoid Cryopreservation→ Organ Chip Manufacturing→ Standardization in MPS→ Quality Control in MPS→ Validation Standards→

Drug Discovery→ Toxicity Testing→ Disease Modeling→ Personalized Medicine→ Cancer Research→ Rare Diseases→ Infectious Diseases→ Regenerative Medicine→ Cosmetics Testing→

FDA Modernization Act 2.0→ FDA Modernization Act 3.0→ FDA ISTAND Program→ NCATS Tissue Chip Program→ EMA 3Rs Initiative→ EPA NAMs Strategy→ ICH Guidelines→ OECD Test Guidelines→ ARPA-H→

Emulate→ CN Bio→ TissUse→ Mimetas→ InSphero→ Organovo→ HUB Organoids→ Hesperos→ AxoSim→ Altis Biosystems→ Kirkstall→ Nortis→ MatTek→ EpiSkin→ BioIVT→ Crown Bioscience→ Recursion→ Insilico Medicine→ Quris AI→

Market Overview→ Organ-on-Chip Market→ Organoid Market→ Digital Twin Market→ AI Drug Discovery Market→ Funding Trends→ Geographic Analysis→

Getting Started with Organoids→ Organ Chip Protocols→ iPSC Differentiation→ Drug Testing Methods→ Biomarker Selection→ Data Analysis→ Quality Assurance→ Vendor Selection→ Regulatory Submission→

About Patient Analog→ References & Sources→ System Framework→ Legal Information→